JP2011521986A5 - - Google Patents

Download PDF

Info

Publication number
JP2011521986A5
JP2011521986A5 JP2011512021A JP2011512021A JP2011521986A5 JP 2011521986 A5 JP2011521986 A5 JP 2011521986A5 JP 2011512021 A JP2011512021 A JP 2011512021A JP 2011512021 A JP2011512021 A JP 2011512021A JP 2011521986 A5 JP2011521986 A5 JP 2011521986A5
Authority
JP
Japan
Prior art keywords
alkyl
independently
halo
compound according
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2011512021A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011521986A (ja
Filing date
Publication date
Priority claimed from GBGB0810228.7A external-priority patent/GB0810228D0/en
Application filed filed Critical
Publication of JP2011521986A publication Critical patent/JP2011521986A/ja
Publication of JP2011521986A5 publication Critical patent/JP2011521986A5/ja
Pending legal-status Critical Current

Links

JP2011512021A 2008-06-04 2009-06-04 癌に対する4,6−ジフェニルピリド−2−オン Pending JP2011521986A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0810228.7A GB0810228D0 (en) 2008-06-04 2008-06-04 Novel compounds
GB0810228.7 2008-06-04
PCT/EP2009/004005 WO2009146910A1 (en) 2008-06-04 2009-06-04 4, 6-diphenylpyrid-2-0nes against cancer

Publications (2)

Publication Number Publication Date
JP2011521986A JP2011521986A (ja) 2011-07-28
JP2011521986A5 true JP2011521986A5 (enExample) 2014-06-26

Family

ID=39638174

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011512021A Pending JP2011521986A (ja) 2008-06-04 2009-06-04 癌に対する4,6−ジフェニルピリド−2−オン

Country Status (7)

Country Link
US (2) US8236827B2 (enExample)
EP (1) EP2310370A1 (enExample)
JP (1) JP2011521986A (enExample)
AU (1) AU2009254176A1 (enExample)
CA (1) CA2726939A1 (enExample)
GB (1) GB0810228D0 (enExample)
WO (1) WO2009146910A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012058550A2 (en) * 2010-10-29 2012-05-03 Fox Chase Cancer Center Methods for screening compounds for capability to inhibit premalignant squamous epithelial cell progression to a malignant state
US9101603B2 (en) 2010-11-30 2015-08-11 Institute For Cancer Research Targeting of CYP1B1 in the treatment of head and neck cancer and lung cancer
CN103387574A (zh) * 2012-05-07 2013-11-13 北京以岭药业有限公司 一种表小檗碱的合成方法
CN107591180A (zh) * 2016-07-07 2018-01-16 中芯国际集成电路制造(上海)有限公司 非挥发性存储器及其读取数据的方法
WO2018011376A1 (en) * 2016-07-13 2018-01-18 Centre National De La Recherche Scientifique - Cnrs - Pyrimidinone derivatives and uses thereof to neutralize the biological activity of chemokines

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0123777D0 (en) 2001-10-03 2001-11-21 Cancer Res Ventures Ltd Substituted chalcones as therapeutic agents
US7910742B2 (en) * 2005-09-29 2011-03-22 Abbott Laboratories Survivin inhibitors
CA2685106A1 (en) * 2007-04-25 2008-11-06 Exelixis, Inc. 6-phenylpyrimidinones as pim modulators

Similar Documents

Publication Publication Date Title
JP2014500861A5 (enExample)
JP2010530897A5 (enExample)
JP2015024998A5 (enExample)
JP2013519675A5 (enExample)
JP2016503793A5 (enExample)
JP2013518107A5 (enExample)
JP2009502743A5 (enExample)
JP2020500862A5 (enExample)
JP2013510123A5 (enExample)
JP2016520618A5 (enExample)
JP2009531376A5 (enExample)
JP2016518437A5 (enExample)
JP2011518833A5 (enExample)
JP2013032389A5 (enExample)
JP2010077141A5 (enExample)
JP2018529650A5 (enExample)
JP2013509429A5 (enExample)
JP2014526554A5 (enExample)
WO2009082818A8 (en) Novel c-21-keto lupane derivatives preparation and use thereof
JP2011521986A5 (enExample)
JP2016540749A5 (enExample)
JP2019516739A5 (enExample)
JP2011527299A5 (enExample)
JP2016522254A5 (enExample)
JP2016530242A5 (enExample)